Oral Metadon vid hjärtkirurgi (OMICS)
Oral Metadon Inom Hjärtkirurgi
The purpose of this study is to compare the effects of administration of oral methadone preoperatively and intravenous methadone upon induction of general anesthesia on postoperative pain for patients undergoing elective cardiac surgery.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 4
Kontakter och platser
Studieorter
-
-
Minnesota
-
Rochester, Minnesota, Förenta staterna, 55905
- Mayo Clinic in Rochester
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
• Undergoing elective cardiac surgery
Exclusion Criteria:
- Chronic pain requiring opioid medications as an outpatient
- Opioid use disorder on medication assistance treatment
- Prolonged QTc >500ms
- Chronic kidney disease with eGFR < 30mL/min
- Documented cirrhosis
- Intolerance to methadone
- Admitted inpatient in an intensive care unit (ICU) immediately prior to surgery
- Pregnancy at the time of surgery
- Subsequent surgeries after index surgery
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Trippel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Intravenous methadone intraoperatively
Subjects in the IV methadone arm will receive methadone intravenously during cardiac surgery |
Patients will receive 0.3mg/kg methadone intravenously after induction of general anesthesia |
|
Experimentell: Oral methadone, immediately prior to transport
Subjects in the oral methadone arm will receive methadone orally prior to cardiac surgery |
Patients will receive 0.4mg/kg PO methadone immediately prior to transport to the operating room |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Amount of opioid medication used 72 hours post-extubation
Tidsram: From hospital admission for surgery to 72 hours after the patient is extubated postoperatively
|
Opioid medication used at 72 hours post-extubation will be reported in morphine milligram equivalents |
From hospital admission for surgery to 72 hours after the patient is extubated postoperatively
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Amount of opioid medication used 24 hours post-extubation
Tidsram: From hospital admission for surgery to 24 hours after the patient is extubated postoperatively
|
Opioid medication used at 24 hours post-extubation will be reported in morphine milligram equivalents |
From hospital admission for surgery to 24 hours after the patient is extubated postoperatively
|
|
Amount of opioid medication used 48 hours post-extubation
Tidsram: From hospital admission for surgery to 48 hours after the patient is extubated postoperatively
|
Opioid medication used at 48 hours post-extubation will be reported in morphine milligram equivalents |
From hospital admission for surgery to 48 hours after the patient is extubated postoperatively
|
|
Amount of opioid medication required throughout hospitalization
Tidsram: From the time the patient is extubated until the time the patient leaves the hospital, approximately 10 days. Safety to leave the hospital is determined by the cardiac surgery team and can be several days after surgery or longer.
|
Opioid medication required from extubation until hospital discharge will be reported in morphine milligram equivalents |
From the time the patient is extubated until the time the patient leaves the hospital, approximately 10 days. Safety to leave the hospital is determined by the cardiac surgery team and can be several days after surgery or longer.
|
|
Amount of opioid medication required prior to extubation
Tidsram: From arrival in the ICU until extubation, approximately 6 hours. Safety of extubation is determined by the intensive care unit team and usually occurs within several hours of ICU arrival, although this can be variable.
|
Opioid medication required between the end of surgery and extubation will be documented in morphine milligram equivalents. |
From arrival in the ICU until extubation, approximately 6 hours. Safety of extubation is determined by the intensive care unit team and usually occurs within several hours of ICU arrival, although this can be variable.
|
|
Pain scores after extubation
Tidsram: 6 hours, 12 hours, 24 hours, 48 hours, and 72 hours after extubation
|
Pain will be assessed by nursing staff using a numerical rating scale from 0-10, with 0 being no pain and 10 being the worst pain imaginable. |
6 hours, 12 hours, 24 hours, 48 hours, and 72 hours after extubation
|
|
Time to extubation
Tidsram: From the time the patient arrives in the ICU intubated until the time they are successfully extubated, approximately 12 hours. Safety of extubation is determined by the ICU team and usually occurs within several hours, although this can be variable.
|
This outcome will monitor the time in minutes from when a patient arrives in the ICU to the time the breathing tube is removed (extubation). |
From the time the patient arrives in the ICU intubated until the time they are successfully extubated, approximately 12 hours. Safety of extubation is determined by the ICU team and usually occurs within several hours, although this can be variable.
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Krishnan Ramanujan, M.D., Mayo Clinic
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 25-007292
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .